Cargando…
Peptide drugs accelerate BMP‐2‐induced calvarial bone regeneration and stimulate osteoblast differentiation through mTORC1 signaling
Both W9 and OP3‐4 were known to bind the receptor activator of NF‐κB ligand (RANKL), inhibiting osteoclastogenesis. Recently, both peptides were shown to stimulate osteoblast differentiation; however, the mechanism underlying the activity of these peptides remains to be clarified. A primary osteobla...
Autores principales: | Sugamori, Yasutaka, Mise‐Omata, Setsuko, Maeda, Chizuko, Aoki, Shigeki, Tabata, Yasuhiko, Murali, Ramachandran, Yasuda, Hisataka, Udagawa, Nobuyuki, Suzuki, Hiroshi, Honma, Masashi, Aoki, Kazuhiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5094554/ https://www.ncbi.nlm.nih.gov/pubmed/27345003 http://dx.doi.org/10.1002/bies.201600104 |
Ejemplares similares
-
The inhibitory effects of a RANKL-binding peptide on articular and periarticular bone loss in a murine model of collagen-induced arthritis: a bone histomorphometric study
por: Kato, Genki, et al.
Publicado: (2015) -
mTORC1 and mTORC2 Differentially Regulate Cell Fate Programs to Coordinate Osteoblastic Differentiation in Mesenchymal Stromal Cells
por: Schaub, Theres, et al.
Publicado: (2019) -
mTORC1 Signaling Promotes Osteoblast Differentiation from Preosteoblasts
por: Chen, Jianquan, et al.
Publicado: (2015) -
Interleukin 6 promotes BMP9-induced osteoblastic differentiation through Stat3/mTORC1 in mouse embryonic fibroblasts
por: Wang, Shi-Yu, et al.
Publicado: (2023) -
mTORC1 plays an important role in osteoblastic regulation of B-lymphopoiesis
por: Martin, Sally K., et al.
Publicado: (2018)